Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Energy

The Small cap Wrap: Lumos Diagnostics secures US$317 million US distribution milestone for FebriDx®; Spenda targets $36.1 billion Australian B2B payments market; Prescient Therapeutics initiates first US site for Phase 2a trial and more

Once again we saw some strong news come to the fore for several small cap companies.

The S&P/ASX 200 Index closed down 68.50 points or 0.79% on Wednesday to finish at 8,561.80, pulling back after reaching a 20-day high earlier in the session. Among the laggards, Newmont Corporation led the declines with a 5.73% fall, followed by Genesis Minerals Limited, down 4.28%. Despite the daily drop, the benchmark index remains up 0.27% over the past five sessions and sits just 0.89% below its 52-week high.

Meanwhile, the S&P/ASX Small Ordinaries Index edged down 5.20 points or 0.16% to close at 3,289.30. However, it has gained 1.80% over the last five trading days and once again we saw some strong news come to the fore for several small cap companies.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK